Role of betaine in liver disease-worth revisiting or has the die been cast?

Betaine modulates oxidative stress, inflammation, apoptosis, autophagy, and Akt/mTOR signaling in methionine-choline deficiency-induced fatty liver disease

(2019) Milena Veskovic et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Non-Alcoholic Fatty Liver Disease in Patients with HIV Infection

(2018) Marianthi Papagianni et al.   AIDS REVIEWS

Betaine attenuates chronic alcohol-induced fatty liver by broadly regulating hepatic lipid metabolism

(2017) Wenjuan Yang et al.   Molecular Medicine Reports

Betaine chemistry, roles, and potential use in liver disease

(2016) Christopher R. Day et al.   BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS

Nonalcoholic steatohepatitis is associated with a state of betaine-insufficiency

(2016) Silvia Sookoian et al.   LIVER INTERNATIONAL

How to prevent alcoholic liver disease

(2015) S.W. French   EXPERIMENTAL AND MOLECULAR PATHOLOGY

Adverse Signaling of Scavenger Receptor Class B1 and PGC1s in Alcoholic Hepatosteatosis and Steatohepatitis and Protection by Betaine in Rat

(2014) Ravi Varatharajalu et al.   AMERICAN JOURNAL OF PATHOLOGY

Efficacy and Safety of Oral Betaine Glucuronate in Non-alcoholic Steatohepatitis

(2012) Federico Miglio et al.   ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH

Betaine improved adipose tissue function in mice fed a high-fat diet: a mechanism for hepatoprotective effect of betaine in nonalcoholic fatty liver disease

(2010) Zhigang Wang et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Betaine for nonalcoholic fatty liver disease: Results of a randomized placebo-controlled trial

(2009) Manal F. Abdelmalek et al.   HEPATOLOGY